Negative Delta-Prostate-Specific Antigen Time Ratio as Potential New Marker of Progression-Free Survival in Castration-Resistant Prostate Cancer Patients Treated With First-Line Enzalutamide or Docetaxel

Purpose We propose a new potential marker of progression-free survival (PFS) called negative delta-prostate-specific antigen (PSA) time ratio (NDPSATR) and compare it with conventional PSA response, defined as PSA decline ≥50% at 12 weeks from pretreatment baseline (PSAR50) in metastatic castration-...

詳細記述

書誌詳細

主要な著者:	Tae Hwan Kim, Seol Ho Choo, Kang Hee Shim, Sun Il Kim
フォーマット:	Artigo
言語:	Inglês
出版事項:	Korean Urological Oncology Society 2023-11-01
シリーズ:	Journal of Urologic Oncology
主題:	prostate neoplasms docetaxel prostate-specific antigen survival
オンライン･アクセス:	http://www.e-juo.org/upload/pdf/juo-21-3-271.pdf
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!